Seeking Alpha

TheeSeer's  Instablog

TheeSeer
Send Message
After obtaining a BA in History (From my beloved Rutgers University) and a JD in Law, I've had several disparate careers including Artist Management, Music Production and as a Regional Partner Manager with four tech companies. I also server as a Registered Bond trader and Precious Metals Trader.... More
  • Ormp Is Not A Threat To MNKD's Afreeza For Some Time If At All.
    • ORMP is not a threat to MNKD's Afreeza for quite some time if at all. ORMP has yet to begin FDA 3 studies and Afreeza is more than just an inhaled version of insuln. Its patented insulin is "prandial" meaning it mimics the natural insulin faster and more like the kind the human pancreas delivers. The "dreamboat" inhaler less than palm size, can be adapted to many other drug delivery systems, for future revenue opportunities.

      Afreeza is ready to go now and anxiously awaited by those that were trial subjects in the FDA 3 trials. Afreeza was almost approved before except for a request to test their newly introduced tiny inhaler which was done with FDA cooperation. Finally this market is huge and various combinations of treatments will be worked out between Doctor and patient. As with asthmatics many patients will no doubt become comfortable with the inhaler long before ORMP's drug hits the market and will stick with it's convenience and fast action.

    • In an Interview dated Jan 24, 2014 Search for "Maintaining Glucose Control at Mealtime" Diabetes Care net interviewed Dr. Howard Zisser - MD, director of research and technology at the Sansum Diabetes Research Institute, in collaboration with the University of California, Santa Barbara (UCSB) in collaboration with the University of California, Santa Barbara (UCSB) - about the ultra-rapid inhaled insulin in collaboration with a artificial pancreas in a clinical study, which was funded by JDRF.

      Below are the comments about the study's results:

      1) JDRF's Aaron Kowalski, PhD, vice president of treatment therapies, stated, quote the early results of this exciting study are compelling. While more data are required, this protocol represents a potentially revolutionary way of combining the artificial pancreas with a simple-to-use inhaled insulin (Afreeza) to significantly improve blood sugar levels.

      2) Dr. Zisser: quote The inhaled insulin gives us another arrow in our quiver-so to speak-to manage diabetes. I think it will be a great drug, especially for type 2 diabetes. Glucose monitoring has gotten much better and people can see how their decisions and activities affect their glucose in real time. Not only the value, but what direction it's heading in, and with this learning, make better decisions in their care.

      I'm long MNKD.

    Disclosure: I am long MNKD.

    Jan 29 6:27 PM | Link | 1 Comment
  • Medical Tourism And USA Debt Reduction

    How about some good news? The developed countries and especially the United States is sitting on an untapped gold mine of historic proportions if they can control one very large issue.

    Specifically I am talking about the healthcare industry and the desire of many people from around the world to receive medical treatment in the United States. The simple idea that the USA could become the largest "Medical Tourism" destination in the world is supported by my world travel over the last 25 years and the perception by many of my contacts worldwide, whether correct or incorrect, that Medical care in all its forms are superior in the USA

    Were it not for bizarre and frustrating immigration procedures a system of medical tourism visas could be established to encourage what would be a flood of income producing visits to the USA. Shortages of nurses and facilities could easily be addressed with special work visas for qualified personnel as has been the case for nurses over the years.

    This would have a multiplier effect on exporting all types of medical devices made or distributed in the USA and provide a job stimulus and even perhaps help older Americans with opportunities in all types of support occupations. The expansion of domestic facilities would also rationalize and increase the efficiency of the domestic case load.

    So what is standing in the way of turning the elderly revolution into a thriving industry reducing our debt? Simple, the comparative cost of US services and drugs as compared to other developed nations and more specifically the vast gap in costs as compared to developing countries. If we are truly in a "Global Economy" we must compete in this vital area as we do in cars and other services. The sooner we confront the lawyers, medical associations, insurance companies, hospitals, drug companies etc that unfairly target the USA as a special case or who add unnecessary inflated costs to end results the sooner we could unlock a boom lasting through this century.

    If you think I exaggerate here is a quote and link to comparative healthcare costs worldwide. www.pbs.org/newshour/rundown/2012/10/hea....html

    "$8,233 per year That's how much the U.S. spends per person. Worth it?That figure is more than two-and-a-half times more than most developed nations in the world, including relatively rich European countries like France, Sweden and the United Kingdom. On a more global scale, it means U.S. health care costs now eat up 17.6 percent of GDP."

    Call your representative and demand he face down the special interests!!!

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

    Additional disclosure: I have no active stock positions currently but day trade frequently without regard to industry on a technical basis.

    May 06 9:16 AM | Link | Comment!
Full index of posts »
Latest Followers

StockTalks

  • Ormp Is Not A Threat To MNKD's Afreeza For Some Time If At All. http://seekingalpha.com/p/1kax7
    Jan 29, 2014
  • Vale signs a long term transport deal indicating a possible break from the trading range along with the general bullish nature of Brazil.
    Sep 26, 2009
More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.